Early Prediction of Alzheimer's Disease Dementia Based on Baseline
  Hippocampal MRI and 1-Year Follow-Up Cognitive Measures Using Deep Recurrent
  Neural Networks by Li, Hongming & Fan, Yong
EARLY PREDICTION OF ALZHEIMER’S DISEASE DEMENTIA BASED ON BASELINE 
HIPPOCAMPAL MRI AND 1-YEAR FOLLOW-UP COGNITIVE MEASURES USING DEEP 
RECURRENT NEURAL NETWORKS 
 
Hongming Li, Yong Fan 
for the Alzheimer's Disease Neuroimaging Initiative 
Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 
19104, USA 
 
ABSTRACT 
 
Multi-modal biological, imaging, and neuropsychological 
markers have demonstrated promising performance for 
distinguishing Alzheimer’s disease (AD) patients from 
cognitively normal elders. However, it remains difficult to 
early predict when and which mild cognitive impairment 
(MCI) individuals will convert to AD dementia. Informed by 
pattern classification studies which have demonstrated that 
pattern classifiers built on longitudinal data could achieve 
better classification performance than those built on cross-
sectional data, we develop a deep learning model based on 
recurrent neural networks (RNNs) to learn informative 
representation and temporal dynamics of longitudinal 
cognitive measures of individual subjects and combine them 
with baseline hippocampal MRI for building a prognostic 
model of AD dementia progression. Experimental results on 
a large cohort of MCI subjects have demonstrated that the 
deep learning model could learn informative measures from 
longitudinal data for characterizing the progression of MCI 
subjects to AD dementia, and the prognostic model could 
early predict AD progression with high accuracy. 
 
Index Terms— Prognosis, recurrent neural networks, 
longitudinal data, Alzheimer’s disease 
 
1. INTRODUCTION 
 
Alzheimer's disease (AD) is the most prevalent 
neurodegenerative disorder, and individuals with mild 
cognitive impairment (MCI) are at a higher risk to develop 
AD [1]. Although promising performance has been achieved 
for distinguishing progressive MCI (pMCI) subjects from 
stable MCI (sMCI) subjects in a pattern classification setting, 
it remains difficult at baseline to predict which and when MCI 
individuals will convert to AD dementia. 
    Neuropsychological tests and a variety of different 
biological and imaging markers have been explored for 
diagnosis and following the progression of AD [2-8], such as 
genetic data, cerebrospinal fluid (CSF) biomarkers, magnetic 
resonance imaging (MRI), and positron emission tomography 
(PET). It has been demonstrated that pattern classifiers built 
upon these measures could distinguish AD patients from 
subjects with normal cognition (NC) with high accuracy, and 
recent studies have demonstrated that better performance can 
be achieved if longitudinal rather than cross-sectional data are 
used to build the classifiers [9-11]. 
    Longitudinal changes of biomarkers and imaging markers 
have been investigated for AD diagnosis/prognosis, for 
instance, changes of neuropsychological measures [12], 
atrophy rate in cortical thickness and subcortical volume [9, 
13-15], and changes in brain tissue intensity/density map 
[10]. Most longitudinal data based prediction models require 
different subjects to have data at the same time points. 
However, missing data is a ubiquitous problem in 
longitudinal studies. Such a problem is typically 
circumvented by imputing missing data [11]. Multivariate 
functional principal component (MFPC) scores [12] have 
been used to represent longitudinal makers for handling 
missing or irregular data. However, certain assumption is 
adopted in MFPC to model the latent longitudinal process, 
which may not be appropriate for different types of markers. 
    The early prediction of AD dementia has been typically 
modeled as a classification problem, for instance, 
distinguishing sMCI subjects from pMCIs. However, the 
classification performance is dependent on a cut-off threshold 
of follow-up duration that is used to define pMCI and sMCI. 
Moreover, the cohorts of pMCI and sMCI subjects are 
typically heterogeneous regardless of the threshold used. 
Furthermore, the classification setting for prediction of AD 
dementia does not provide timing information about when 
MCI individuals will cross the threshold to AD dementia. 
Several studies [11, 12, 16] have focused on the prediction of 
time of progression to AD under a time-to-event analysis 
setting, and promising performance have been obtained.  
    Recently, deep learning techniques built upon recurrent 
neural networks (RNNs) with a long short term memory 
(LSTM) [17] structure have achieved remarkable advances in 
sequence modeling, such as machine translation and 
functional MRI modeling [18, 19], indicating RNNs might be 
better tools for characterizing longitudinal data. 
    In this study, a LSTM autoencoder is adopted to learn 
compact and informative representation from longitudinal 
cognitive measures for predicting progression of MCI 
subjects to AD dementia. These representations could encode 
temporal dynamics of longitudinal cognitive measures and 
characterize the progression trajectory of MCI subjects 
without any explicit assumption regarding the longitudinal 
process behind the measures. Based on the learned 
representations and baseline hippocampal MRI data, a 
prognostic model is built in a time-to-event setting. 
Particularly, Cox regression model is adopted to estimate the 
risk of progression of MCI subjects to AD dementia. The 
proposed model is applied to a large cohort obtained from the 
Alzheimer's Disease Neuroimaging Initiative (ADNI), and 
the experimental results have demonstrated that the proposed 
model could obtain promising prognostic performance, and 
cognitive measures and imaging based measures could 
provide complementary information for the prognosis. 
 
2. METHODS AND MATERIAL 
 
To build an early prediction model of AD dementia based on 
longitudinal data, we first train a LSTM autoencoder [20] to 
learn compact representations and encode temporal dynamics 
of longitudinal measures for each subject. The learned 
representations are then combined with baseline imaging data 
as features to build a prognosis model under a time-to-event 
analysis setting. 
Table1. Demographic information of the dataset used in this study. 
ADNI   sMCI pMCI 
1 
Age (years) 74.92±7.51 74.58±7.16 
Gender (M/F) 114/61 132/76 
MMSE 27.29±1.78 26.78±1.74 
Conversion/censor time (months) 49.2±36.6 30.5±25.6 
GO&2 
Age 71.39±7.47 72.68±6.97 
Gender (M/F) 182/150 60/47 
MMSE 28.29±1.62 27.35±1.77 
Conversion/censor time (months) 43.2±16.7 24.88±14.5 
sMCI: stable MCI who remained as MCI at the last visit; pMCI: 
progressive MCI who converted to AD before the last visit. 
 
2.1. Data 
 
Cognitive measures of 822 MCI subjects at baseline, 6 
months, and 12 months were obtained from ADNI-1, GO & 
2, including 13-item version of the Alzheimer’s Disease 
Assessment Scale-Cognitive subscale (ADAS-Cog13), Rey 
Auditory Verbal Learning Test (RAVLT) immediate, 
RAVLT learning, Functional Assessment Questionnaire 
(FAQ), and Mini-Mental State Examination (MMSE). 
Baseline characteristics of the subjects included are 
summarized in table 1. Baseline structural MRI scans were 
also obtained for these subjects to extract hippocampal 
imaging measures. 
 
2.2. LSTM based feature representation 
 
Given the longitudinal cognitive measures at multiple time 
points for each subject, we learn informative and compact 
representations to encode the subject’s overall longitudinal 
cognitive performance and its temporal changes/trajectory 
across multiple time points. The LSTM autoencoder [20] 
provides an ideal tool for achieving this goal. The architecture 
of the LSTM autoencoder adopted in this study is illustrated 
in Fig. 1. It contains two parts, encoder and decoder. The 
encoder receives the input data of multiple time points and 
handles the encoding of input measures and their temporal 
dynamics between consecutive time points. The decoder is 
utilized to reconstruct the input measures at different time 
points step by step in a reverse order, based on the learned 
representations by the encoder. While the network is 
optimized to minimize the deviation between the 
reconstructed and input measures, the learned representation 
by the encoder is expected to characterize the overall 
cognitive performance and its dynamics of the input 
longitudinal measures. 
 
Fig. 1. LSTM autoencoder for longitudinal feature extraction. 
As illustrated in Fig. 1, our autoencoder contains 2 LSTM 
layers for the encoder and decoder respectively. 𝑓𝑡 and 𝑓𝑡 are 
the input and reconstructed cognitive measures at time point 
𝑡 (𝑡=1,2,3 for illustration), 𝑊𝑒𝑖  are the trainable parameters 
of the 𝑖 -th LSTM layer of the encoder, and 𝑊𝑑𝑖  are the 
trainable parameters of the 𝑖-th LSTM layer of the decoder. 
The trainable parameters are those involved in the forget gate, 
input gate, cell state and hidden state within one LSTM layer. 
Euclidean distance between the reconstructed and input 
measures is used as the objective function to optimize the 
trainable parameters. The number of LSTM layers was 
chosen to achieve generalizable performance with a small 
number of trainable parameters. 
In this study, the autoencoder of cognitive measures was 
built on longitudinal cognitive measures of subjects from 
ADNI-1 cohort. Once the autoencoder was obtained, the 
encoder was then applied to all the MCI patients from ADNI-
1 and GO&2 cohorts to extract their latent features from 
longitudinal cognitive measures, which were then used for 
the following prognostic analysis. 
 
2.3. Prognostic modeling 
 
Given the latent representations of longitudinal cognitive 
information, they were combined with baseline hippocampal 
MRI based measures to build a prognostic model using Cox 
regression [21].  
Particularly, cognitive measures including ADAS-Cog13, 
RAVLT immediate, RAVLT learning, FAQ, and MMSE 
were used to learn LSTM encoded cognitive measures. 
Imaging features from baseline hippocampal MRI data was 
extracted as an imaging based risk of progression to AD using 
a deep learning based prognostic framework [22]. Age, 
gender, education years, and APOEε4 status at baseline were 
used as covariates in the modeling. 
 
Fig. 2. Schematic diagram of the time-to-event prognosis model.  
    Cox regression model was built on data of MCI subjects of 
ADNI-1, and its prognostic performance was evaluated based 
on the data of MCI subjects of ADNI-GO&2. The schematic 
illustration of the prognostic modeling is illustrated in Fig. 2. 
We built prediction models on longitudinal cognitive data of 
the first 2 and 3 time points separately (within 1-year follow-
up) along with the baseline hippocampal imaging based 
measures.  
 
3. RESULTS 
 
3.1. Experimental setting 
 
We implemented the LSTM autoencoder using Tensorflow. 
Two LSTM layers were adopted as shown in Fig. 1, and the 
number of hidden nodes in each LSTM layer was set to 5 (the 
dimension of the LSTM encoded cognitive measures, the 
same as the number of input cognitive measures at each time 
point). Adam optimization technique was adopted to optimize 
the autoencoder, with a base learning rate set to 0.01 and 
updated using a stepwise policy by dropping the learning rate 
by a factor of 0.1 after every 20000 iterations. The maximum 
iteration number of the training procedure was set to 100000, 
and the batch size was set to 64. The autoencoder was trained 
on a Nvidia Titan Xp graphics processing unit (GPU). 
We compared the proposed prediction model with those 
built on longitudinal cognitive measures only or cognitive 
measures at single time points. The prognostic performance 
was evaluated using concordance measure (C-index). 
 
3.2. Experimental results 
 
The prognosis performance of the proposed prediction 
models is demonstrated in Fig. 3. For the LSTM based 
prediction models built on the longitudinal data, the 6m 
model was built on data at baseline (bl) and 6-month visits, 
and the 12m model was built on data at bl, 6-month, and 12-
month visits. It is worth noting that if a pMCI subject 
converted to AD at Visit-ID or data at Visit-ID were not 
available for a sMCI subject, only data at visits before the 
Visit-ID were used. When the prediction models built upon 
ADNI-1 longitudinal cognitive data of 3 and 2 time points 
applied to ADNI-GO&2 subjects, they achieved C-index 
values of 0.896 and 0.873 respectively, better than the 
prediction models built upon single-visit data at 12 and 6 
months (p=0.019 and 0.552 respectively). All these 
prediction models had better prediction performance than the 
model built upon the baseline cognitive measures (a C-index 
value of 0.848), while the LSTM based prediction models 
were significantly better (p<0.05). When both longitudinal 
cognitive measures and baseline imaging measures were 
used, prediction models achieved C-index values of 0.901 
and 0.889 at 12 and 6 months respectively, significantly 
better (p<0.006) than a model built on baseline cognitive 
measures and imaging measures (a C-index value of 0.866). 
 
Fig. 3. Prognostic performance of prediction models built on single 
visit cognitive data (blue), longitudinal cognitive data with 5 LSTM 
encoded features (red), and longitudinal cognitive data with 
hippocampal MRI based features (magenta). 
 
As shown in Fig. 3, the prediction models built upon data 
of any single visit had worse prediction performance than the 
models built upon longitudinal data, and the models built on 
data of later time points had better performance than those 
built on data of earlier time points. Best prognostic 
performance was obtained when LSTM encoded cognitive 
representation was combined with imaging based features 
from baseline hippocampal MRI data [22], indicating that 
clinical measures and imaging data could provide 
complementary information for the prognosis. Moreover, we 
expect that the prognostic performance could be further 
improved if longitudinal imaging data are incorporated in the 
prediction model. 
 
Fig. 4. Prediction performance based on longitudinal data with 
different numbers of features learned by LSTM autoencoder. 
We have also evaluated how the number of hidden nodes 
in each LSTM layer impacted the prognostic performance. 
The prognostic performance of prediction models built on 
longitudinal data with different numbers (3, 5, 7, and 9) of 
features learned by the LSTM autoencoder and baseline 
imaging data are shown in Fig. 4, demonstrating that the 
performance was relatively stable and all the longitudinal 
data based models outperformed the model built on baseline 
cognitive and imaging measures when the number of hidden 
nodes was larger than 3. 
4. CONCLUSION 
 
In this study, we developed a deep learning based method to 
characterize longitudinal dynamics of cognitive measures 
and built prognostic models based on baseline hippocampal 
MRI measures and the learned longitudinal dynamics to 
predict individual MCI subjects’ progression to AD. 
Evaluation results have demonstrated that the proposed 
model achieved promising performance for predicting MCI 
subjects’ progression to AD using data within 1-year follow-
up. Future work will be devoted to model optimization and 
more validation on external data cohorts. 
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